Overview |
bs-7023R-PE-Cy7 |
IFN-Alpha Polyclonal Antibody, PE-Cy7 Conjugated |
WB |
This antibody will detect all Human and Mouse Interferon alpha subtypes |
Mouse, Rat |
Specifications |
PE-Cy7 |
Rabbit |
KLH conjugated synthetic peptide derived from Mouse IFNA1 |
101-190/190 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
15962 |
P01572 |
Secreted |
IFNA; IFN-a; IFN-_; Interferon alpha; Interferon-alpha; IFNA1; IFNA2; IFNA5; IFNA6; IFNA8/6; IFNA7; IFNA9; IFNA11; IFNA12; IFNA13; IFNA15; IFNA16; IFNA6T; IFNAB; IFNA4; Pan Interferon alpha; IFNA13; IFNA1/13; IFNA7; IFNA10; IFNA14; IFNA17; IFNA21; IFNA8. |
Interferons(IFNs) are proteins made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites or tumor cells. They belong to the large class of glycoproteins known as cytokines. IFNs stimulate the production of two enzymes: a protein kinase and an oligoadenylate synthetase. They allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors. IFNs can activate immune cells, such as natural killer cells and macrophages; they increase recognition of infection or tumor cells by up-regulating antigen presentation to T lymphocytes; and they also increase the ability of uninfected host cells to resist new infection by virus. Leukocyte interferon is produced predominantly by B lymphocytes. Immune interferon is produced by mitogen- or antigen-stimulated T lymphocytes. |
Application Dilution |
WB |
1:300-5000 |